Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 April 2019 | Story Valentino Ndaba | Photo Charl Devenish
Accounting Students
Pictured are 8 of the 64 UFS School of Accountancy students who form part of the 84.2% pass rate achievers.

Students from the University of the Free State (UFS) School of Accountancy achieved a 84.2% pass rate compared to the national average of 76.2% during the Initial Test of Competence (ITC) examination facilitated by the South African Institute of Chartered Accountants (SAICA).

A total of 64 out of 76 UFS students who attempted the ITC for the first time were successful in the examination. The ITC is known for its challenging nature.  Demographically, our African black students outperformed the 62.1% national pass rate by attaining an impressive 80.6%.

Collective congratulations

Prof Hentie van Wyk, Programme Director at the school, attributed diligence for the high pass rate. “This is due to our student-centred teaching module that was introduced four years ago and committed academic staff of the School of Accountancy from the first to the fourth year.”

Further future surge expected

“With the coming June 2019 ITC sitting, our pass rate for 2019 will most probably be more than 90%. Our three-year rolling average for 2015-2017, 2016-2018 and 2017-2019 were 83%, 86% and 90% respectively. Hopefully we can maintain the upward curve,” said Prof Van Wyk.

News Archive

UFS researcher explores the future cost of cancer
2017-01-10

 Description: 001 Dr Alicia Sherriff Tags: 001 Dr Alicia Sherriff

Dr Alicia Sherriff, Head the Department of Oncology
at the UFS Faculty of Health Sciences, co-authored
an article in the South African Medical Journal.

Photo: Charl Devenish

Cancer is on an exponential rise globally, and the cost of treatment is a growing international problem. South Africa alone is expected to see a 78% increase in cancer cases. Dr Alicia Sheriff, Head of the Department of Oncology, collaborated on and co-authored a research paper for the South African Medical Journal on the future of oncology treatment in the country, along with doctors from various universities across South Africa. The article, titled "The future cost of cancer: interdisciplinary cost management strategy", looks at the prognosis of cancer management in the country.

Cancer is on the rise

There is a visible growth of the cancer disease in the developing world. Rapidly changing lifestyles, uncontrolled urbanisation, pollution, and population ageing are some dynamics that provide a lethal cocktail of infectious and lifestyle risk factors that leave people at a higher risk of developing cancer.

The simultaneous increase in cancer incidence has increased the cost of treatment exponentially. The cost of cancer treatment is multitiered, making the provision of care for cancer patients a high-risk business. A combination of treatment delays, limited resources, differently skilled personnel, high patient volumes and advanced disease stage on presentation all place a bigger burden on the delivery of optimal cancer care outcomes.

Adoption of new strategies

According to the doctors, innovative thinking to embrace technology, combined with a preventive approach, as well as lowering the cost of treatment drugs should be prioritised. So should the commercialisation of new technologies that will diagnose and treat cancer in its early stages. They also encourage interdisciplinary research funding in South Africa as a way to better understand the demographic and molecular dynamics of cancer in the country, along with retaining more oncologists in the public health sector.

Efficient solutions to curb cancer mortality

The doctors assert there is a need to continue to look for more efficient measures to best treat the disease, and hopefully bring about a change in mortality levels in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept